Skip to Content

465 (Rizatriptan benzoate 5 mg (base))

Pill imprint 465 has been identified as Rizatriptan benzoate 5 mg (base).

Rizatriptan is used in the treatment of migraine and belongs to the drug class antimigraine agents. Risk cannot be ruled out during pregnancy. Rizatriptan 5 mg (base) is not a controlled substance under the Controlled Substance Act (CSA).

Rizatriptan benzoate 5 mg (base) 465
Discount Card Promo
Rizatriptan benzoate
Imprint:
465
Strength:
5 mg (base)
Color:
Brown
Shape:
Round
Availability:
Prescription only
Drug Class:
Antimigraine agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Manufacturer:
Glenmark Generics Inc., USA
National Drug Code (NDC):
68462-0465
Inactive Ingredients:
lactose monohydrate
microcrystalline cellulose
corn starch
ferric oxide red
magnesium stearate
silicon dioxide

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide